ATA747378A - Verfahren zur herstellung von neuen 1-aryl-alkyl-imidazolderivaten und deren salzen - Google Patents
Verfahren zur herstellung von neuen 1-aryl-alkyl-imidazolderivaten und deren salzenInfo
- Publication number
- ATA747378A ATA747378A AT0747378A AT747378A ATA747378A AT A747378 A ATA747378 A AT A747378A AT 0747378 A AT0747378 A AT 0747378A AT 747378 A AT747378 A AT 747378A AT A747378 A ATA747378 A AT A747378A
- Authority
- AT
- Austria
- Prior art keywords
- aryl
- salts
- alkyl
- imidazole derivatives
- producing new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4351277 | 1977-10-19 | ||
GB4353277 | 1977-10-19 | ||
GB398478 | 1978-02-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA747378A true ATA747378A (de) | 1982-07-15 |
AT370095B AT370095B (de) | 1983-02-25 |
Family
ID=27254350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0747378A AT370095B (de) | 1977-10-19 | 1978-10-18 | Verfahren zum herstellen von neuen 1-aryl-alkyl-imidazolderivaten und deren salzen |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS5488268A (de) |
AT (1) | AT370095B (de) |
AU (1) | AU522055B2 (de) |
CA (1) | CA1111433A (de) |
DE (1) | DE2845406A1 (de) |
DK (1) | DK464278A (de) |
FI (1) | FI783175A (de) |
IE (1) | IE47749B1 (de) |
IL (1) | IL55858A (de) |
IT (1) | IT1109321B (de) |
MC (1) | MC1221A1 (de) |
ZA (1) | ZA785863B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55313A (en) * | 1978-06-13 | 1980-01-05 | Kissei Pharmaceut Co Ltd | Imidazole derivative |
JPS6047257B2 (ja) * | 1979-07-19 | 1985-10-21 | 旭化成株式会社 | 新規な塩基性物質およびその製造法 |
US4430445A (en) | 1979-07-19 | 1984-02-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel basic imidazolylmethylstyrene compound, its polymer, a process for the preparation thereof and a use as ion exchange resin |
JPS5681566A (en) * | 1979-12-05 | 1981-07-03 | Yoshitomi Pharmaceut Ind Ltd | Imidazole derivative |
GR78234B (de) * | 1981-03-10 | 1984-09-26 | Ciba Geigy Ag | |
JPS57188570A (en) * | 1981-05-14 | 1982-11-19 | Shionogi & Co Ltd | Benzylazole derivative |
HU191627B (en) * | 1982-08-14 | 1987-03-30 | Wellcome Found | Process for preparing imidazole derivatives and salts thereof futher pharmaceutical compositions containing such compounds as active substances |
US4581370A (en) * | 1983-07-12 | 1986-04-08 | Schering A.G. | Antiarrhythmic imidazoliums |
JPH01316365A (ja) * | 1988-03-24 | 1989-12-21 | Shikoku Chem Corp | 1−ベンジルイミダゾール化合物、該化合物の合成方法及び該化合物を用いるポリエポキシ樹脂の硬化方法 |
-
1978
- 1978-10-18 CA CA313,653A patent/CA1111433A/en not_active Expired
- 1978-10-18 ZA ZA785863A patent/ZA785863B/xx unknown
- 1978-10-18 AT AT0747378A patent/AT370095B/de not_active IP Right Cessation
- 1978-10-18 FI FI783175A patent/FI783175A/fi not_active Application Discontinuation
- 1978-10-18 DE DE19782845406 patent/DE2845406A1/de not_active Withdrawn
- 1978-10-18 AU AU40824/78A patent/AU522055B2/en not_active Expired
- 1978-10-18 IT IT51570/78A patent/IT1109321B/it active
- 1978-10-18 IE IE2067/78A patent/IE47749B1/en unknown
- 1978-10-18 DK DK464278A patent/DK464278A/da not_active Application Discontinuation
- 1978-10-18 JP JP12830378A patent/JPS5488268A/ja active Granted
- 1978-10-18 MC MC781335A patent/MC1221A1/xx unknown
- 1978-11-02 IL IL55858A patent/IL55858A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IT7851570A0 (it) | 1978-10-18 |
FI783175A (fi) | 1979-04-20 |
MC1221A1 (fr) | 1979-07-20 |
AT370095B (de) | 1983-02-25 |
JPS6233227B2 (de) | 1987-07-20 |
JPS5488268A (en) | 1979-07-13 |
AU4082478A (en) | 1980-04-24 |
DK464278A (da) | 1979-04-20 |
AU522055B2 (en) | 1982-05-13 |
ZA785863B (en) | 1980-05-28 |
CA1111433A (en) | 1981-10-27 |
IL55858A0 (en) | 1979-01-31 |
IE47749B1 (en) | 1984-06-13 |
DE2845406A1 (de) | 1979-05-03 |
IE782067L (en) | 1979-04-19 |
IT1109321B (it) | 1985-12-16 |
IL55858A (en) | 1982-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT364851B (de) | Verfahren zur herstellung von neuen thienothiazinderivaten und von deren salzen | |
ATA601078A (de) | Verfahren zur herstellung von neuen nitro- imidazolen und von deren salzen | |
AT362792B (de) | Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen | |
AT361459B (de) | Verfahren zur herstellung von neuen stilben- derivaten und deren salzen | |
AT371454B (de) | Verfahren zur herstellung von neuen prostanderivaten und von deren salzen | |
AT366043B (de) | Verfahren zur herstellung von neuen chinazolinderivaten und deren salzen | |
AT361139B (de) | Verfahren zur herstellung von neuen morphin- derivaten und von deren salzen | |
AT374188B (de) | Verfahren zur herstellung von neuen a-alkylimidazolderivaten und deren salzen | |
AT367412B (de) | Verfahren zur herstellung von neuen 2-substituierten 5-hydroxy-1h-imidazol-4carboxamidderivaten und von deren salzen | |
AT365166B (de) | Verfahren zur herstellung von neuen peptidderivaten und deren salzen | |
AT366666B (de) | Verfahren zur herstellung von neuen amidinosulfon- saeurederivaten und von deren salzen | |
AT365188B (de) | Verfahren zur herstellung von neuen 7-azabenzimidazolen und deren salzen | |
AT371112B (de) | Verfahren zur herstellung von neuen 2-imino-imidazolidin-derivaten und von deren salzen | |
AT363937B (de) | Verfahren zur herstellung von neuen bispidinderivaten und deren salzen | |
AT360664B (de) | Verfahren zur herstellung von neuen morphin- derivaten und von deren salzen | |
ATA747378A (de) | Verfahren zur herstellung von neuen 1-aryl-alkyl-imidazolderivaten und deren salzen | |
ATA57578A (de) | Verfahren zur herstellung von neuen azacycloalkanen und azacycloalkenen und deren derivaten und salzen | |
AT367410B (de) | Verfahren zur herstellung von neuen 2-benzazepin- verbindungen und deren salzen | |
AT360999B (de) | Verfahren zur herstellung von neuen amidino- -benzylpyrimidinen und deren salzen | |
AT365183B (de) | Verfahren zur herstellung von neuen 4-amino-2-piperidinochinazolinderivaten und deren salzen | |
ATA73877A (de) | Verfahren zur herstellung von neuen oxadiazolopyrimidinderivaten und von deren salzen | |
AT358050B (de) | Verfahren zur herstellung von neuen triazolo- thieno-diazepin-1-onen und deren salzen | |
ATA320578A (de) | Verfahren zur herstellung von neuen benzylpyrimidinen und deren salzen | |
AT366057B (de) | Verfahren zur herstellung von neuen peptidderivaten und deren salzen | |
ATA356778A (de) | Verfahren zur herstellung von neuen 4-hydroxy- thiazolidin-2-thion-derivaten und von deren salzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |